1
|
Daftary A, Furin J, Zelnick JR, Venkatesan N, Steingart K, Smelyanskaya M, Seepamore B, Schoeman I, Reid M, Padayatchi N, O Donnell MR, Mistry N, McKenna L, Mahbub T, Macdonald H, Loveday M, Law S, LaCourse SM, Jaramillo E, Janssen R, Hirsch-Moverman Y, Friedland G, Creswell J, Chorna Y, Chikovore J, Brigden G, Boffa J, Boehme C, Atre S, Amico KR, Acquah R, Engel N. TB and women: a call to action. Int J Tuberc Lung Dis 2020; 24:1312-1315. [PMID: 33317679 DOI: 10.5588/ijtld.20.0414] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Affiliation(s)
- A Daftary
- Dahdaleh Institute of Global Health Research, York University, Toronto, ON, Canada,Centre for the AIDS Programme of Research in South Africa, University of KwaZulu-Natal, Durban, South Africa
| | - J Furin
- Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA
| | - J R Zelnick
- Touro College Graduate School of Social Work, New York, NY, USA
| | | | - K Steingart
- Cochrane Infectious Diseases Group, Liverpool School of Tropical Medicine, Liverpool, UK
| | | | - B Seepamore
- Department of Social Work, University of KwaZulu-Natal, Durban, South Africa
| | | | - M Reid
- Institute for Global Health Sciences, University of California San Francisco, San Francisco, CA, USA
| | - N Padayatchi
- Centre for the AIDS Programme of Research in South Africa, University of KwaZulu-Natal, Durban, South Africa
| | - M R O Donnell
- Columbia University Medical Centre, New York, NY, USA
| | - N Mistry
- Dahdaleh Institute of Global Health Research, York University, Toronto, ON, Canada
| | - L McKenna
- Treatment Action Group, New York, NY, USA
| | - T Mahbub
- Médecins Sans Frontières, Mumbai, India
| | - H Macdonald
- University of Cape Town, Cape Town, South Africa
| | - M Loveday
- Centre for the AIDS Programme of Research in South Africa, University of KwaZulu-Natal, Durban, South Africa, Health Systems Research Unit, South African Medical Research Council, Cape Town, South Africa
| | - S Law
- Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA
| | - S M LaCourse
- Departments of Medicine and Global Health, University of Washington, Seattle, WA, USA
| | - E Jaramillo
- World Health Organization, Geneva, Switzerland
| | - R Janssen
- Department of Health, Ethics & Society, Maastricht University, Maastricht, the Netherlands
| | - Y Hirsch-Moverman
- ICAP at Columbia University´s Mailman School of Public Health, New York, NY, USA
| | - G Friedland
- Yale School of Medicine, Yale University, New Haven, CT, USA
| | - J Creswell
- Stop TB Partnership, Geneva, Switzerland
| | - Y Chorna
- Europe TB Coalition, Kiev, Ukraine
| | - J Chikovore
- Human Sciences Research Council, Durban, South Africa
| | - G Brigden
- Department of Tuberculosis, International Union Against Tuberculosis and Lung Disease (The Union), Geneva, Switzerland
| | - J Boffa
- Dahdaleh Institute of Global Health Research, York University, Toronto, ON, Canada, Centre for Rural Health, University of KwaZulu-Natal, Durban, South Africa
| | - C Boehme
- Foundation for Innovative New Diagnostics, Geneva, Switzerland
| | - S Atre
- D Y Patil Medical College, Hospital & Research Centre, Pune, India
| | - K R Amico
- University of Michigan, Ann Arbor, MI, USA
| | - R Acquah
- Médecins Sans Frontières, Cape Town, South Africa
| | - N Engel
- Department of Health, Ethics & Society, Maastricht University, Maastricht, the Netherlands
| |
Collapse
|
2
|
Zelnick JR, Seepamore B, Daftary A, Amico KR, Bhengu X, Friedland G, Padayatchi N, Naidoo K, O'Donnell MR. Training social workers to enhance patient-centered care for drug-resistant TB-HIV in South Africa. Public Health Action 2018; 8:25-27. [PMID: 29581940 DOI: 10.5588/pha.17.0114] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/08/2017] [Accepted: 01/22/2018] [Indexed: 11/10/2022] Open
Abstract
KwaZulu-Natal, South Africa, is the epicenter of an epidemic of drug-resistant tuberculosis (DR-TB) and human immunodeficiency virus (HIV) co-infection, characterized by low rates of medication adherence and retention in care. Social workers may have a unique role to play in improving DR-TB-HIV outcomes. We designed, implemented and evaluated a model-based pilot training course on patient-centered care, treatment literacy in DR-TB and HIV coinfection, patient support group facilitation, and self-care. Ten social workers participated in a 1-day training course. Post-training questionnaire scores showed significant overall gains (P = 0.003). A brief training intervention may be a useful and feasible way to engage social workers in patient-centered care for DR-TB and HIV coinfection.
Collapse
Affiliation(s)
- J R Zelnick
- Touro College Graduate School of Social Work, New York, New York, USA.,Centre for AIDS Programme of Research in South Africa, South African Medical Research Council HIV-TB Pathogenesis and Treatment Research Unit, Durban, South Africa
| | - B Seepamore
- Centre for AIDS Programme of Research in South Africa, South African Medical Research Council HIV-TB Pathogenesis and Treatment Research Unit, Durban, South Africa.,School of Applied Human Sciences, University of KwaZulu-Natal, Durban, South Africa
| | - A Daftary
- Centre for AIDS Programme of Research in South Africa, South African Medical Research Council HIV-TB Pathogenesis and Treatment Research Unit, Durban, South Africa.,McGill International TB Centre, McGill University Health Centre, McGill University, Montreal, Quebec, Canada
| | - K R Amico
- Department of Health Behavior and Health Education, School of Public Health, University of Michigan, Ann Arbor, Michigan, USA
| | - X Bhengu
- King DinuZulu Hospital Complex, Sydenham, South Africa
| | - G Friedland
- Yale School of Medicine, New Haven, Connecticut, USA
| | - N Padayatchi
- Centre for AIDS Programme of Research in South Africa, South African Medical Research Council HIV-TB Pathogenesis and Treatment Research Unit, Durban, South Africa
| | - K Naidoo
- Centre for AIDS Programme of Research in South Africa, South African Medical Research Council HIV-TB Pathogenesis and Treatment Research Unit, Durban, South Africa
| | - M R O'Donnell
- Centre for AIDS Programme of Research in South Africa, South African Medical Research Council HIV-TB Pathogenesis and Treatment Research Unit, Durban, South Africa.,Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University Medical Center, New York, New York, USA.,Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, USA
| |
Collapse
|
3
|
Zelnick JR, O'Donnell MR, Ahuja SD, Chua A, Sullivan Meissner J. Health care provider perspectives on tuberculosis care for foreign-born populations in New York City. Int J Tuberc Lung Dis 2018; 20:1625-1632. [PMID: 27931338 DOI: 10.5588/ijtld.16.0299] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Tuberculosis (TB) in foreign-born patients is a key determinant of TB epidemiology in low-burden settings. In New York City (NYC), foreign-born TB populations are heterogeneous and face diverse challenges in accessing care. OBJECTIVE To characterize barriers and facilitators to health care services and identify potential mechanisms to improve TB care for foreign-born patients in NYC. DESIGN Semi-structured interviews with health care providers identified through the NYC TB registry and snowball sampling. Transcripts were analyzed using a modified grounded theory approach. RESULTS Fourteen providers from private practice (21%), community clinic (36%), and hospitals (43%) were interviewed. Barriers clustered into thematic areas: interrelated social and economic issues that impact TB care and treatment (documentation status, poverty, mental/behavioral health issues), challenges of fragmented health system (care continuity, costs), latent tuberculous infection, and relative lack of resources and significant barriers for clinic and private practice providers. Health care providers' deep commitment to foreign-born TB patients was evidenced by their attitudes and actions. CONCLUSION Improving access to TB care for foreign-born patients in NYC requires strategies that address specific social, economic and structural barriers. Improving linkages between private providers and public health initiatives is a key challenge. Health care providers' commitment to foreign-born communities is a significant resource.
Collapse
Affiliation(s)
- J R Zelnick
- Touro College Graduate School of Social Work, New York
| | - M R O'Donnell
- Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University Medical Center, New York, Department of Epidemiology, Mailman School of Public Health, Columbia University, New York
| | - S D Ahuja
- Bureau of Tuberculosis Control, New York City Department of Health and Mental Hygiene, New York
| | - A Chua
- Division of Pulmonary Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, New York, New York, USA
| | - J Sullivan Meissner
- Bureau of Tuberculosis Control, New York City Department of Health and Mental Hygiene, New York
| |
Collapse
|
4
|
O'Donnell MR, Daftary A, Frick M, Hirsch-Moverman Y, Amico KR, Senthilingam M, Wolf A, Metcalfe JZ, Isaakidis P, Davis JL, Zelnick JR, Brust JCM, Naidu N, Garretson M, Bangsberg DR, Padayatchi N, Friedland G. Re-inventing adherence: toward a patient-centered model of care for drug-resistant tuberculosis and HIV. Int J Tuberc Lung Dis 2017; 20:430-4. [PMID: 26970149 DOI: 10.5588/ijtld.15.0360] [Citation(s) in RCA: 50] [Impact Index Per Article: 7.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Despite renewed focus on molecular tuberculosis (TB) diagnostics and new antimycobacterial agents, treatment outcomes for patients co-infected with drug-resistant TB and human immunodeficiency virus (HIV) remain dismal, in part due to lack of focus on medication adherence as part of a patient-centered continuum of care. OBJECTIVE To review current barriers to drug-resistant TB-HIV treatment and propose an alternative model to conventional approaches to treatment support. DISCUSSION Current national TB control programs rely heavily on directly observed therapy (DOT) as the centerpiece of treatment delivery and adherence support. Medication adherence and care for drug-resistant TB-HIV could be improved by fully implementing team-based patient-centered care, empowering patients through counseling and support, maintaining a rights-based approach while acknowledging the responsibility of health care systems in providing comprehensive care, and prioritizing critical research gaps. CONCLUSION It is time to re-invent our understanding of adherence in drug-resistant TB and HIV by focusing attention on the complex clinical, behavioral, social, and structural needs of affected patients and communities.
Collapse
Affiliation(s)
- M R O'Donnell
- Division of Pulmonary Allergy and Critical Care Medicine, Columbia University Medical Center, New York, USA; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, USA; Centre for the AIDS Programme of Research in South Africa, South African Medical Research Council TB HIV Pathogenesis Extramural Unit, Durban, South Africa
| | - A Daftary
- Centre for the AIDS Programme of Research in South Africa, South African Medical Research Council TB HIV Pathogenesis Extramural Unit, Durban, South Africa; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
| | - M Frick
- Treatment Action Group, New York, USA
| | - Y Hirsch-Moverman
- Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, USA; International Center for AIDS Care and Treatment Programs, Mailman School of Public Health, Columbia University, New York, New York, USA
| | - K R Amico
- Department of Health Behavior and Health Education, School of Public Health, University of Michigan, Ann Arbor, Michigan, USA
| | | | - A Wolf
- Division of Pulmonary Allergy and Critical Care Medicine, Columbia University Medical Center, New York, USA
| | - J Z Metcalfe
- Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, California, USA
| | | | - J L Davis
- Division of Pulmonary Allergy and Critical Care Medicine, Columbia University Medical Center, New York, USA
| | - J R Zelnick
- Touro College Graduate School of Social Work, New York, New York, USA
| | - J C M Brust
- Montefiore Medical Center & Albert Einstein College of Medicine, Bronx, New York, USA
| | - N Naidu
- Centre for the AIDS Programme of Research in South Africa, South African Medical Research Council TB HIV Pathogenesis Extramural Unit, Durban, South Africa
| | - M Garretson
- Division of Pulmonary Allergy and Critical Care Medicine, Columbia University Medical Center, New York, USA
| | | | - N Padayatchi
- Centre for the AIDS Programme of Research in South Africa, South African Medical Research Council TB HIV Pathogenesis Extramural Unit, Durban, South Africa
| | - G Friedland
- Yale University School of Public Health, New Haven, Connecticut, USA; Yale University School of Medicine, New Haven, Connecticut, USA
| |
Collapse
|